Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Electron Kebebew

Showing results (321-330 of 378) with videos related to

Pageof 38
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 17, 2018
Identification of Differential Transcriptional Patterns in Primary and Secondary HyperparathyroidismSamira Mercedes Sadowski, Marc Pusztaszeri, Marie-Claude Brulhart-Meynet, et al.
Cancer Letters|August 20, 2025
Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosisChandrayee Ghosh, Tejinder Pal Khaket, Viswanath Gunda, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 30, 2014
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemiaChunzhang Yang, Zhengping Zhuang, Stephanie M J Fliedner, et al.
Investigational New Drugs|January 28, 2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinomaDavid C Smith, Matthias Kroiss, Electron Kebebew, et al.
Surgery|December 26, 2006
Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantationFrederic Triponez, Electron Kebebew, David Dosseh, et al.
The Lancet. Oncology|November 5, 2020
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid glandSriram Gubbi, Shilpa Thakur, Shirisha Avadhanula, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 14, 2019
ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORSAmit Tirosh, J Keith Killian, Yuelin Jack Zhu, et al.
Journal of the American College of Surgeons|July 24, 2012
No need to abandon unilateral parathyroid surgeryRichard Hodin, Peter Angelos, Sally Carty, et al.
Journal of the American College of Surgeons|February 7, 2018
Probability of Positive Genetic Testing Results in Patients with Family History of Primary HyperparathyroidismMustapha El Lakis, Pavel Nockel, Apostolos Gaitanidis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2012
Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumorSahzene Yavuz, William F Simonds, Lee S Weinstein, et al.
Pageof 38

Showing results (321-330 of 378) with videos related to

Sort By:
Pageof 38
The Journal of Clinical Endocrinology and Metabolism|April 17, 2018
Identification of Differential Transcriptional Patterns in Primary and Secondary HyperparathyroidismSamira Mercedes Sadowski, Marc Pusztaszeri, Marie-Claude Brulhart-Meynet, et al.
Cancer Letters|August 20, 2025
Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosisChandrayee Ghosh, Tejinder Pal Khaket, Viswanath Gunda, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 30, 2014
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemiaChunzhang Yang, Zhengping Zhuang, Stephanie M J Fliedner, et al.
Investigational New Drugs|January 28, 2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinomaDavid C Smith, Matthias Kroiss, Electron Kebebew, et al.
Surgery|December 26, 2006
Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantationFrederic Triponez, Electron Kebebew, David Dosseh, et al.
The Lancet. Oncology|November 5, 2020
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid glandSriram Gubbi, Shilpa Thakur, Shirisha Avadhanula, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 14, 2019
ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORSAmit Tirosh, J Keith Killian, Yuelin Jack Zhu, et al.
Journal of the American College of Surgeons|July 24, 2012
No need to abandon unilateral parathyroid surgeryRichard Hodin, Peter Angelos, Sally Carty, et al.
Journal of the American College of Surgeons|February 7, 2018
Probability of Positive Genetic Testing Results in Patients with Family History of Primary HyperparathyroidismMustapha El Lakis, Pavel Nockel, Apostolos Gaitanidis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2012
Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumorSahzene Yavuz, William F Simonds, Lee S Weinstein, et al.
Pageof 38